Listed

Immuneering Corp

IMRXNasdaqCIK 1790340HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q4 FY2023
Operating income−$25.8m, Q3 FY2026
Net income−$24.2m, Q3 FY2026
Line itemUnitQ4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Revenue$m0.0Revenue, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:Revenues. 10-K filed 2024-03-01, accession 0001790340-24-000024. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Cost of revenue$m0.0Cost of revenue, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2024-03-01, accession 0001790340-24-000024. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Gross profit$m0.0Gross profit, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-03-01, accession 0001790340-24-000024. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m11.9Research and development, Q4 FY2023, three months to 2023-12-31$11.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-20, accession 0001790340-25-000042. Derived: 12-month figure less the 9-month figure.Report this figure11.2Research and development, Q1 FY2024, three months to 2024-03-31$11.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-05, accession 0001790340-25-000061.Report this figure10.7Research and development, Q2 FY2024, three months to 2024-06-30$10.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-13, accession 0001790340-25-000104.Report this figure11.3Research and development, Q3 FY2024, three months to 2024-09-30$11.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001790340-25-000135.Report this figure14.9Research and development, Q4 FY2024, three months to 2024-12-31$14.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-06, accession 0001790340-26-000042. Derived: 12-month figure less the 9-month figure.Report this figure11.5Research and development, Q1 FY2025, three months to 2025-03-31$11.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001790340-26-000057.Report this figure10.5Research and development, Q2 FY2025, three months to 2025-06-30$10.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001790340-26-000091.Report this figure10.9Research and development, Q3 FY2025, three months to 2025-09-30$10.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure9.3Research and development, Q4 FY2025, three months to 2025-12-31$9.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-06, accession 0001790340-26-000042. Derived: 12-month figure less the 9-month figure.Report this figure10.6Research and development, Q1 FY2026, three months to 2026-03-31$10.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001790340-26-000057.Report this figure14.0Research and development, Q2 FY2026, three months to 2026-06-30$14.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001790340-26-000091.Report this figure20.7Research and development, Q3 FY2026, three months to 2026-09-30$20.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure
Operating income$m(16.3)Operating income, Q4 FY2023, three months to 2023-12-31−$16.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-20, accession 0001790340-25-000042. Derived: 12-month figure less the 9-month figure.Report this figure(15.3)Operating income, Q1 FY2024, three months to 2024-03-31−$15.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-05, accession 0001790340-25-000061.Report this figure(14.9)Operating income, Q2 FY2024, three months to 2024-06-30−$14.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-13, accession 0001790340-25-000104.Report this figure(15.3)Operating income, Q3 FY2024, three months to 2024-09-30−$15.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001790340-25-000135.Report this figure(18.6)Operating income, Q4 FY2024, three months to 2024-12-31−$18.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-06, accession 0001790340-26-000042. Derived: 12-month figure less the 9-month figure.Report this figure(15.5)Operating income, Q1 FY2025, three months to 2025-03-31−$15.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001790340-26-000057.Report this figure(14.8)Operating income, Q2 FY2025, three months to 2025-06-30−$14.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001790340-26-000091.Report this figure(15.4)Operating income, Q3 FY2025, three months to 2025-09-30−$15.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure(13.8)Operating income, Q4 FY2025, three months to 2025-12-31−$13.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-06, accession 0001790340-26-000042. Derived: 12-month figure less the 9-month figure.Report this figure(15.3)Operating income, Q1 FY2026, three months to 2026-03-31−$15.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001790340-26-000057.Report this figure(19.0)Operating income, Q2 FY2026, three months to 2026-06-30−$19.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001790340-26-000091.Report this figure(25.8)Operating income, Q3 FY2026, three months to 2026-09-30−$25.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure
Net income$m(15.1)Net income, Q4 FY2023, three months to 2023-12-31−$15.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-20, accession 0001790340-25-000042. Derived: 12-month figure less the 9-month figure.Report this figure(14.3)Net income, Q1 FY2024, three months to 2024-03-31−$14.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001790340-25-000135.Report this figure(14.1)Net income, Q2 FY2024, three months to 2024-06-30−$14.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001790340-25-000135.Report this figure(14.6)Net income, Q3 FY2024, three months to 2024-09-30−$14.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001790340-25-000135.Report this figure(18.1)Net income, Q4 FY2024, three months to 2024-12-31−$18.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-06, accession 0001790340-26-000042. Derived: 12-month figure less the 9-month figure.Report this figure(15.0)Net income, Q1 FY2025, three months to 2025-03-31−$15.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure(14.4)Net income, Q2 FY2025, three months to 2025-06-30−$14.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure(15.0)Net income, Q3 FY2025, three months to 2025-09-30−$15.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure(11.6)Net income, Q4 FY2025, three months to 2025-12-31−$11.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-06, accession 0001790340-26-000042. Derived: 12-month figure less the 9-month figure.Report this figure(13.5)Net income, Q1 FY2026, three months to 2026-03-31−$13.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure(17.3)Net income, Q2 FY2026, three months to 2026-06-30−$17.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure(24.2)Net income, Q3 FY2026, three months to 2026-09-30−$24.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure
Diluted EPS$ per sharenot reported(0.49)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-05, accession 0001790340-25-000061.Report this figure(0.47)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-13, accession 0001790340-25-000104.Report this figure(0.49)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001790340-25-000135.Report this figurenot reported(0.42)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001790340-26-000057.Report this figure(0.40)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001790340-26-000091.Report this figure(0.38)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figurenot reported(0.21)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001790340-26-000057.Report this figure(0.27)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001790340-26-000091.Report this figure(0.37)Diluted EPS, Q3 FY2026, three months to 2026-09-30−$0.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure
Basic EPS$ per sharenot reported(0.49)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.49 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-05, accession 0001790340-25-000061.Report this figure(0.47)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.47 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-13, accession 0001790340-25-000104.Report this figure(0.49)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.49 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001790340-25-000135.Report this figurenot reported(0.42)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.42 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001790340-26-000057.Report this figure(0.40)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001790340-26-000091.Report this figure(0.38)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figurenot reported(0.21)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001790340-26-000057.Report this figure(0.27)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001790340-26-000091.Report this figure(0.37)Basic EPS, Q3 FY2026, three months to 2026-09-30−$0.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure

Balance sheet

Cash and equivalents$58.2m, Q3 FY2026
Shareholders' equity$168.7m, Q3 FY2026
Line itemUnitFY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Cash and equivalents$m59.4Cash and equivalents, FY2023, at 2023-12-31$59.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-20, accession 0001790340-25-000042.Report this figure66.3Cash and equivalents, Q1 FY2024, at 2024-03-31$66.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-07, accession 0001790340-24-000056.Report this figure59.7Cash and equivalents, Q2 FY2024, at 2024-06-30$59.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-06, accession 0001790340-24-000066.Report this figure45.2Cash and equivalents, Q3 FY2024, at 2024-09-30$45.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-13, accession 0001790340-24-000080.Report this figure36.1Cash and equivalents, FY2024, at 2024-12-31$36.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-06, accession 0001790340-26-000042.Report this figure35.9Cash and equivalents, Q1 FY2025, at 2025-03-31$35.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-05, accession 0001790340-25-000061.Report this figure26.4Cash and equivalents, Q2 FY2025, at 2025-06-30$26.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-13, accession 0001790340-25-000104.Report this figure228Cash and equivalents, Q3 FY2025, at 2025-09-30$227.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001790340-25-000135.Report this figure129Cash and equivalents, FY2025, at 2025-12-31$128.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure47.3Cash and equivalents, Q1 FY2026, at 2026-03-31$47.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001790340-26-000057.Report this figure41.3Cash and equivalents, Q2 FY2026, at 2026-06-30$41.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001790340-26-000091.Report this figure58.2Cash and equivalents, Q3 FY2026, at 2026-09-30$58.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure
Current assets$m89.1Current assets, FY2023, at 2023-12-31$89.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-20, accession 0001790340-25-000042.Report this figure74.4Current assets, Q1 FY2024, at 2024-03-31$74.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-07, accession 0001790340-24-000056.Report this figure63.7Current assets, Q2 FY2024, at 2024-06-30$63.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-06, accession 0001790340-24-000066.Report this figure55.3Current assets, Q3 FY2024, at 2024-09-30$55.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0001790340-24-000080.Report this figure39.6Current assets, FY2024, at 2024-12-31$39.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-06, accession 0001790340-26-000042.Report this figure38.2Current assets, Q1 FY2025, at 2025-03-31$38.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-05, accession 0001790340-25-000061.Report this figure27.7Current assets, Q2 FY2025, at 2025-06-30$27.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-13, accession 0001790340-25-000104.Report this figure229Current assets, Q3 FY2025, at 2025-09-30$229.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001790340-25-000135.Report this figure176Current assets, FY2025, at 2025-12-31$176.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure161Current assets, Q1 FY2026, at 2026-03-31$161.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-15, accession 0001790340-26-000057.Report this figure158Current assets, Q2 FY2026, at 2026-06-30$158.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001790340-26-000091.Report this figure151Current assets, Q3 FY2026, at 2026-09-30$150.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure
Total assets$m103Total assets, FY2023, at 2023-12-31$102.6m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-20, accession 0001790340-25-000042.Report this figure88.0Total assets, Q1 FY2024, at 2024-03-31$88.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-07, accession 0001790340-24-000056.Report this figure77.1Total assets, Q2 FY2024, at 2024-06-30$77.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0001790340-24-000066.Report this figure68.6Total assets, Q3 FY2024, at 2024-09-30$68.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0001790340-24-000080.Report this figure52.7Total assets, FY2024, at 2024-12-31$52.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-06, accession 0001790340-26-000042.Report this figure50.7Total assets, Q1 FY2025, at 2025-03-31$50.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-05, accession 0001790340-25-000061.Report this figure40.1Total assets, Q2 FY2025, at 2025-06-30$40.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-13, accession 0001790340-25-000104.Report this figure241Total assets, Q3 FY2025, at 2025-09-30$241.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001790340-25-000135.Report this figure232Total assets, FY2025, at 2025-12-31$232.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure215Total assets, Q1 FY2026, at 2026-03-31$214.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-15, accession 0001790340-26-000057.Report this figure202Total assets, Q2 FY2026, at 2026-06-30$202.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001790340-26-000091.Report this figure183Total assets, Q3 FY2026, at 2026-09-30$182.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure
Current liabilities$m7.8Current liabilities, FY2023, at 2023-12-31$7.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-20, accession 0001790340-25-000042.Report this figure5.2Current liabilities, Q1 FY2024, at 2024-03-31$5.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-07, accession 0001790340-24-000056.Report this figure6.8Current liabilities, Q2 FY2024, at 2024-06-30$6.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-06, accession 0001790340-24-000066.Report this figure6.9Current liabilities, Q3 FY2024, at 2024-09-30$6.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0001790340-24-000080.Report this figure7.5Current liabilities, FY2024, at 2024-12-31$7.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-06, accession 0001790340-26-000042.Report this figure5.1Current liabilities, Q1 FY2025, at 2025-03-31$5.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-05, accession 0001790340-25-000061.Report this figure7.5Current liabilities, Q2 FY2025, at 2025-06-30$7.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-13, accession 0001790340-25-000104.Report this figure9.5Current liabilities, Q3 FY2025, at 2025-09-30$9.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001790340-25-000135.Report this figure10.1Current liabilities, FY2025, at 2025-12-31$10.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure5.0Current liabilities, Q1 FY2026, at 2026-03-31$5.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-15, accession 0001790340-26-000057.Report this figure8.1Current liabilities, Q2 FY2026, at 2026-06-30$8.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001790340-26-000091.Report this figure10.8Current liabilities, Q3 FY2026, at 2026-09-30$10.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure
Total liabilities$m12.0Total liabilities, FY2023, at 2023-12-31$12.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-20, accession 0001790340-25-000042.Report this figure9.3Total liabilities, Q1 FY2024, at 2024-03-31$9.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-07, accession 0001790340-24-000056.Report this figure10.8Total liabilities, Q2 FY2024, at 2024-06-30$10.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-06, accession 0001790340-24-000066.Report this figure10.8Total liabilities, Q3 FY2024, at 2024-09-30$10.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0001790340-24-000080.Report this figure11.3Total liabilities, FY2024, at 2024-12-31$11.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-06, accession 0001790340-26-000042.Report this figure8.8Total liabilities, Q1 FY2025, at 2025-03-31$8.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-05, accession 0001790340-25-000061.Report this figure11.1Total liabilities, Q2 FY2025, at 2025-06-30$11.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-13, accession 0001790340-25-000104.Report this figure13.1Total liabilities, Q3 FY2025, at 2025-09-30$13.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001790340-25-000135.Report this figure13.5Total liabilities, FY2025, at 2025-12-31$13.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure8.3Total liabilities, Q1 FY2026, at 2026-03-31$8.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-15, accession 0001790340-26-000057.Report this figure11.3Total liabilities, Q2 FY2026, at 2026-06-30$11.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001790340-26-000091.Report this figure13.9Total liabilities, Q3 FY2026, at 2026-09-30$13.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure
Shareholders' equity$m90.6Shareholders' equity, FY2023, at 2023-12-31$90.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-06, accession 0001790340-26-000042.Report this figure78.7Shareholders' equity, Q1 FY2024, at 2024-03-31$78.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001790340-25-000135.Report this figure66.3Shareholders' equity, Q2 FY2024, at 2024-06-30$66.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001790340-25-000135.Report this figure57.7Shareholders' equity, Q3 FY2024, at 2024-09-30$57.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001790340-25-000135.Report this figure41.4Shareholders' equity, FY2024, at 2024-12-31$41.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure41.8Shareholders' equity, Q1 FY2025, at 2025-03-31$41.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure28.9Shareholders' equity, Q2 FY2025, at 2025-06-30$28.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure228Shareholders' equity, Q3 FY2025, at 2025-09-30$228.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure218Shareholders' equity, FY2025, at 2025-12-31$218.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure207Shareholders' equity, Q1 FY2026, at 2026-03-31$206.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure191Shareholders' equity, Q2 FY2026, at 2026-06-30$190.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure169Shareholders' equity, Q3 FY2026, at 2026-09-30$168.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure

Cash flow

Operating cash flow−$16.8m, Q3 FY2026
Capital expenditure$15.2k, Q3 FY2026
Line itemUnitQ4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Operating cash flow$m(11.8)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$11.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-20, accession 0001790340-25-000042. Derived: 12-month figure less the 9-month figure.Report this figure(15.5)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$15.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-05, accession 0001790340-25-000061.Report this figure(11.5)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$11.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-13, accession 0001790340-25-000104. Derived: 6-month figure less the 3-month figure.Report this figure(13.5)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$13.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001790340-25-000135. Derived: 9-month figure less the 6-month figure.Report this figure(14.5)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$14.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-06, accession 0001790340-26-000042. Derived: 12-month figure less the 9-month figure.Report this figure(14.1)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$14.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001790340-26-000057.Report this figure(9.4)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$9.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001790340-26-000091. Derived: 6-month figure less the 3-month figure.Report this figure(12.0)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$12.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-29, accession 0001790340-26-000097. Derived: 9-month figure less the 6-month figure.Report this figure(9.8)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$9.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-06, accession 0001790340-26-000042. Derived: 12-month figure less the 9-month figure.Report this figure(18.4)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$18.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001790340-26-000057.Report this figure(16.5)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$16.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001790340-26-000091. Derived: 6-month figure less the 3-month figure.Report this figure(16.8)Operating cash flow, Q3 FY2026, three months to 2026-09-30−$16.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-29, accession 0001790340-26-000097. Derived: 9-month figure less the 6-month figure.Report this figure
Capital expenditure$m0.2Capital expenditure, Q4 FY2023, three months to 2023-12-31$170.9k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-20, accession 0001790340-25-000042. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$37.5k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-05, accession 0001790340-25-000061.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$32.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-13, accession 0001790340-25-000104. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$5.3k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001790340-25-000135. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$9.4k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-06, accession 0001790340-26-000042. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$8.9k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001790340-26-000057.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$2.1k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001790340-26-000091. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$7.3k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-29, accession 0001790340-26-000097. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2025, three months to 2025-12-31$123.9k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-06, accession 0001790340-26-000042. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$79.9k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001790340-26-000057.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$27.4k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001790340-26-000091. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2026, three months to 2026-09-30$15.2k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-29, accession 0001790340-26-000097. Derived: 9-month figure less the 6-month figure.Report this figure

Shares

Diluted shares (weighted)64.71m, Q3 FY2026
Line itemUnitQ1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Diluted shares (weighted)m shares26.4Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3126,442,216 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-07, accession 0001790340-24-000056.Report this figure28.6Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3028,647,450 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-06, accession 0001790340-24-000066.Report this figure29.3Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3029,266,309 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-13, accession 0001790340-24-000080.Report this figure29.4Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3129,370,357 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-05, accession 0001790340-25-000061.Report this figure29.7Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3029,653,355 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-13, accession 0001790340-25-000104.Report this figure29.8Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3029,841,883 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001790340-25-000135.Report this figure35.5Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3135,529,652 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001790340-26-000057.Report this figure36.0Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3035,985,878 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001790340-26-000091.Report this figure39.7Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3039,670,095 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure64.7Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3164,658,809 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001790340-26-000057.Report this figure64.7Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3064,697,219 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001790340-26-000091.Report this figure64.7Diluted shares (weighted), Q3 FY2026, three months to 2026-09-3064,714,194 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-29, accession 0001790340-26-000097.Report this figure

Shares outstanding: 25.94mShares outstanding, period not labelled, at 2021-09-0325,938,064 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2021-09-09, accession 0001558370-21-012336.Report this figure at Sep 3, 2021, from the cover of the 10-Q filed Sep 9, 2021.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 18:24 ET. Listed shows no prices and gives no investment advice.